ProPublica

Journalism in the Public Interest

Cancel

Articles Tagged With 'Nephrogenic Systemic Fibrosis'

GE and Muzzled Radiologist End UK Libel Case

GE Healthcare and a Danish radiologist have settled a British libel suit in which GE claimed that the radiologist had made damaging statements about GE's MRI imaging drug Omniscan.

GE Suit Hushes Scientist Critical of Omniscan

A case over GE's Omniscan MRI drug fuels a debate over British libel law.

FDA Advised to Tighten Restrictions on GE and Covidien MRI Drugs

An FDA advisory panel recommends effectively banning the use of GE’s Omniscan and Covidien’s Optimark in patients with severe kidney disease.

Feds May Tighten Rules on Omniscan, a GE MRI Drug

An FDA review says MRI imaging drugs may be even riskier for kidney patients than it believed previously.

FDA to Take a Second Look at Warnings on MRI Drugs

After issuing a blanket warning about the risk to patients with kidney disease, regulators will reconsider whether to treat some imaging agents differently.

Specter of MRI Disease Haunts GE

Many MRI patients are injected with a GE dye to enhance images. If they have weak kidneys, they might develop a rare and sometimes fatal disease

How Three University Medical Centers Handled GE’s Omniscan

While GE Healthcare argued against special regulatory restrictions on Omniscan, doctors at three prominent U.S. medical centers moved away from the drug on their own.